Our data indicated that a dramatic correlation exists between the fibrosis stage of NASH and the expression of the ferroptosis-related genes CDKN1A and SIRT1. Additionally, the diagnostic model based on CDKN1A and SIRT1 has a remarkable capacity to diagnose NASH. This evidence concerns the gene CDKN1A and metabolic dysfunction-associated steatohepatitis.